DIN 02249057 — REPLAGAL 1 MG
REPLAGAL is a solution of Agalsidase alfa marketed by TAKEDA CANADA INC. The full Agalsidase alfa monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02249057
- Brand name
- REPLAGAL
- Active ingredient
- Agalsidase alfa
- Strength
- 1 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- TAKEDA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Enzyme replacement therapy
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.